150 related articles for article (PubMed ID: 15683447)
1. Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.
Ottosson L; Salomonsson S; Hennig J; Sonesson SE; Dörner T; Raats J; Kuchroo VK; Sunnerhagen M; Wahren-Herlenius M
Scand J Immunol; 2005 Feb; 61(2):109-18. PubMed ID: 15683447
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block.
Salomonsson S; Ottosson L; Säfsten P; Hof D; Brauner H; Sunnerhagen M; Raats J; Wahren-Herlenius M
J Autoimmun; 2004 Mar; 22(2):167-77. PubMed ID: 14987746
[TBL] [Abstract][Full Text] [Related]
3. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
4. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment.
Kamel R; Eftekhari P; Clancy R; Buyon JP; Hoebeke J
J Autoimmun; 2005 Aug; 25(1):72-6. PubMed ID: 16009533
[TBL] [Abstract][Full Text] [Related]
6. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
Salomonsson S; Sonesson SE; Ottosson L; Muhallab S; Olsson T; Sunnerhagen M; Kuchroo VK; Thorén P; Herlenius E; Wahren-Herlenius M
J Exp Med; 2005 Jan; 201(1):11-7. PubMed ID: 15630133
[TBL] [Abstract][Full Text] [Related]
7. Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.
Hoxha A; Ruffatti A; Ambrosi A; Ottosson V; Hedlund M; Ottosson L; Anandapadamanaban M; Sunnerhagen M; Sonesson SE; Wahren-Herlenius M
Clin Exp Immunol; 2016 Dec; 186(3):284-291. PubMed ID: 27548532
[TBL] [Abstract][Full Text] [Related]
8. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
9. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells.
Neufing PJ; Clancy RM; Jackson MW; Tran HB; Buyon JP; Gordon TP
Arthritis Rheum; 2005 Dec; 52(12):3934-42. PubMed ID: 16320341
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
Macht M; Fiedler W; Kürzinger K; Przybylski M
Biochemistry; 1996 Dec; 35(49):15633-9. PubMed ID: 8961925
[TBL] [Abstract][Full Text] [Related]
12. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
13. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block.
Eftekhari P; Sallé L; Lezoualc'h F; Mialet J; Gastineau M; Briand JP; Isenberg DA; Fournié GJ; Argibay J; Fischmeister R; Muller S; Hoebeke J
Eur J Immunol; 2000 Oct; 30(10):2782-90. PubMed ID: 11069058
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
[TBL] [Abstract][Full Text] [Related]
16. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block.
Li JM; Fan WS; Horsfall AC; Anderson AC; Rigby S; Larsson E; Venables PJ
Clin Exp Immunol; 1996 Jun; 104(3):388-93. PubMed ID: 9099920
[TBL] [Abstract][Full Text] [Related]
17. Candidate T cell epitopes of the human La/SSB autoantigen.
Davies ML; Taylor EJ; Gordon C; Young SP; Welsh K; Bunce M; Wordsworth BP; Davidson B; Bowman SJ
Arthritis Rheum; 2002 Jan; 46(1):209-14. PubMed ID: 11817592
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of anti-SS-A/Ro 60-kDa peptide Fab fragments from infiltrating salivary gland lymphocytes of a patient with Sjögren's syndrome.
Suzuki H; Takemura H; Suzuki M; Sekine Y; Kashiwagi H
Biochem Biophys Res Commun; 1997 Mar; 232(1):101-6. PubMed ID: 9125110
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated and nonphosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics.
Coudevylle N; Rokas D; Sakarellos-Daitsiotis M; Krikorian D; Panou-Pomonis E; Sakarellos C; Boussard G; Cung MT
Biopolymers; 2006; 84(4):368-82. PubMed ID: 16453388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
